| Financial Year |
March 31 2023 |
| Monetary Funds |
2,581,046,128.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
102,483,445.49 |
| Accounts Receivable |
1,089,251,033.41 |
| Advances to Suppliers |
72,646,333.60 |
| Other Receivables |
259,277,757.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,617,283,482.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
72,554,602.74 |
| Total Current Assets |
5,794,542,783.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,245,511.59 |
| Long-term Equity Investment |
79,575,351.12 |
| Investment Properties |
201,817,471.52 |
| Fixed Assetes |
4,117,307,763.60 |
| Under-construction Projects |
68,868,369.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
928,117,181.09 |
| R&D expenses |
-- |
| Goodwill |
3,849,599.19 |
| Long-Term Deferred and Prepaid Expenses |
28,528,483.41 |
| Deferred Income Tax Assets |
517,500,912.78 |
| Other Non-Current Assets |
2,163,336.29 |
| Sub-Total of Non-Current Assets |
6,228,877,379.37 |
| Total Assets |
12,023,420,162.79 |
| Short-Term Loans |
790,370,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,639,200,939.59 |
| Accounts Payable |
1,040,661,210.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
100,293,515.55 |
| Taxes Payable |
57,795,734.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
509,464,381.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,599,970.78 |
| Other Current Liabilities |
41,638,064.68 |
| Sub-Total of Current Liabilities |
4,521,095,252.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,427,089.68 |
| Deferred Income Tax Liabilities |
5,295,177.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
304,110,628.02 |
| Total Liabilities |
4,825,205,880.36 |
| Paid-In Capital(Or Share Stock) |
1,173,000,000.00 |
| Capital Surplus |
2,361,999,625.35 |
| Surplus Reserve |
397,948,751.62 |
| LESS:Treasury Stock |
150,097,604.33 |
| Undistributed Profits |
3,406,841,617.84 |
| Minority Stockholder's Interest |
8,521,891.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,189,692,390.48 |
| Owner's Equity（Stockholder's Equity） |
7,198,214,282.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,023,420,162.79 |
